USANA Health Sciences, Inc. (USNA)

USANA Health Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 27, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Cash & Equivalents	145.35	181.77	330.42	288.42	239.83	311.92
Cash & Short-Term Investments	145.35	181.77	330.42	288.42	239.83	311.92
Cash Growth	-60.17%	-44.99%	14.56%	20.26%	-23.11%	32.83%
Other Receivables	-	8.22	7.2	7.21	7.16	7.42
Receivables	-	8.22	7.2	7.21	7.16	7.42
Inventory	90.78	69.74	61.45	67.09	98.32	90.22
Prepaid Expenses	27.94	13.76	11.39	11.38	13.85	8.68
Restricted Cash	-	-	-	-	-	0.96
Other Current Assets	-	5.7	7.28	10.28	5.95	6.08
Total Current Assets	264.07	279.19	417.75	384.38	365.12	425.29
Property, Plant & Equipment	96.21	111.12	107.68	111.69	120.07	117.33
Long-Term Investments	-	20	-	-	-	20
Goodwill	144.29	144.17	17.1	17.37	17.67	17.37
Other Intangible Assets	138.16	151.82	29.92	32.43	30.44	30.8
Long-Term Deferred Tax Assets	24.16	19.64	13.28	9.8	4.84	4.64
Other Long-Term Assets	59.71	22.25	47.03	40.88	39.6	25.47
Total Assets	726.59	748.19	632.76	596.55	577.74	640.89
Accounts Payable	17.1	11.98	10.07	11.05	13.51	18.2
Accrued Expenses	-	79.57	80.84	84.26	97.63	99.13
Short-Term Debt	-	23	0.79	-	-	-
Current Portion of Leases	-	6.01	7.28	6.89	7.08	8.62
Current Income Taxes Payable	-	3.71	3.3	4.97	5.19	7.76
Current Unearned Revenue	-	12.05	13.91	20.88	19.64	15.95
Other Current Liabilities	101.57	3.3	2.66	15.79	17.75	18.42
Total Current Liabilities	118.66	139.63	118.85	143.83	160.79	168.07
Long-Term Leases	-	10.19	5.14	7.68	10.22	12.86
Long-Term Deferred Tax Liabilities	4.47	4.07	4.55	4.07	7.5	12.01
Other Long-Term Liabilities	21.91	7.97	7.02	6.49	4.11	6.3
Total Liabilities	145.04	161.86	135.56	162.08	182.62	199.24
Common Stock	528.07	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	-	75.82	65.66	55.6	50.01	62.46
Retained Earnings	-	478.94	445.22	391.64	344.64	382.79
Comprehensive Income & Other	-	-22.67	-13.7	-12.79	0.46	-3.63
Total Common Equity	528.07	532.11	497.2	434.47	395.12	441.65
Minority Interest	53.48	54.22	-	-	-	-
Shareholders' Equity	581.55	586.33	497.2	434.47	395.12	441.65
Total Liabilities & Equity	726.59	748.19	632.76	596.55	577.74	640.89
Total Debt	-	39.2	13.21	14.57	17.3	21.47
Net Cash (Debt)	145.35	142.56	317.22	273.85	222.54	290.45
Net Cash Growth	-60.17%	-55.06%	15.84%	23.06%	-23.38%	38.81%
Net Cash Per Share	7.75	7.44	16.40	14.18	10.94	13.66
Filing Date Shares Outstanding	18.29	18.9	19.24	19.29	19.32	20.85
Total Common Shares Outstanding	18.29	19.06	19.13	19.21	19.39	21.04
Working Capital	145.4	139.56	298.9	240.55	204.33	257.21
Book Value Per Share	28.87	27.91	25.99	22.62	20.37	20.99
Tangible Book Value	245.63	236.12	450.18	384.67	347.01	393.49
Tangible Book Value Per Share	13.43	12.39	23.53	20.03	17.89	18.70
Land	-	6.36	6.72	6.72	6.99	7.25
Buildings	-	76.68	77.8	78.07	80.82	79.67
Machinery	-	121.16	116.82	113.99	111.47	100.39
Leasehold Improvements	-	12.61	14.34	14.39	15.21	15.24

Updated Oct 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q